Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Schizophrenia, neuroleptic medication and mortality.

Joukamaa M, Heliövaara M, Knekt P, Aromaa A, Raitasalo R, Lehtinen V.

Br J Psychiatry. 2006 Feb;188:122-7.

PMID:
16449697
3.

Prevalence of spontaneous dyskinesia in schizophrenia.

Fenton WS.

J Clin Psychiatry. 2000;61 Suppl 4:10-4. Review.

4.

Schizophrenia and sudden cardiac death: a review.

Koponen H, Alaräisänen A, Saari K, Pelkonen O, Huikuri H, Raatikainen MJ, Savolainen M, Isohanni M.

Nord J Psychiatry. 2008;62(5):342-5. doi: 10.1080/08039480801959323. Review.

PMID:
18752109
5.

Mortality in schizophrenia.

Auquier P, Lançon C, Rouillon F, Lader M, Holmes C.

Pharmacoepidemiol Drug Saf. 2006 Dec;15(12):873-9. Review.

PMID:
17058327
6.

Physical consequences of schizophrenia and its treatment: the metabolic syndrome.

Ryan MC, Thakore JH.

Life Sci. 2002 Jun 7;71(3):239-57. Review.

PMID:
12034344
7.

A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?

Saha S, Chant D, McGrath J.

Arch Gen Psychiatry. 2007 Oct;64(10):1123-31. Review.

PMID:
17909124
8.

Diet, diabetes and schizophrenia: review and hypothesis.

Peet M.

Br J Psychiatry Suppl. 2004 Apr;47:S102-5. Review.

PMID:
15056602
9.

Life expectancy and cardiovascular mortality in persons with schizophrenia.

Laursen TM, Munk-Olsen T, Vestergaard M.

Curr Opin Psychiatry. 2012 Mar;25(2):83-8. doi: 10.1097/YCO.0b013e32835035ca. Review.

PMID:
22249081
10.

Excess early mortality in schizophrenia.

Laursen TM, Nordentoft M, Mortensen PB.

Annu Rev Clin Psychol. 2014;10:425-48. doi: 10.1146/annurev-clinpsy-032813-153657. Epub 2013 Dec 2. Review.

PMID:
24313570
11.

Mortality among patients with schizophrenia.

Simpson JC, Tsuang MT.

Schizophr Bull. 1996;22(3):485-99. Review.

PMID:
8873299
12.

Morbidity and mortality in schizophrenia.

Lwin A, Symeon C, Jan F, Sule A.

Br J Hosp Med (Lond). 2011 Nov;72(11):628-30. Review.

PMID:
22083003
13.

Mortality in schizophrenia: a measurable clinical endpoint.

Bushe CJ, Taylor M, Haukka J.

J Psychopharmacol. 2010 Nov;24(4 Suppl):17-25. doi: 10.1177/1359786810382468. Review.

14.

Schizophrenia and physical health problems.

von Hausswolff-Juhlin Y, Bjartveit M, Lindström E, Jones P.

Acta Psychiatr Scand Suppl. 2009;(438):15-21. doi: 10.1111/j.1600-0447.2008.01309.x. Review.

PMID:
19132962
15.

[Gender differences id schizophrenia].

Laurila J, Saarijärvi S.

Duodecim. 1997;113(6):478-82. Review. Finnish. No abstract available.

PMID:
11370068
16.

[Excess mortality of schizophrenia].

Wernlund AG, Aagaard J.

Ugeskr Laeger. 2015 Mar 23;177(13):V10140556. Review. Danish.

PMID:
25822814
17.

Are there modifiable risk factors which will reduce the excess mortality in schizophrenia?

Wildgust HJ, Beary M.

J Psychopharmacol. 2010 Nov;24(4 Suppl):37-50. doi: 10.1177/1359786810384639. Review.

18.

An outcome measure in schizophrenia: mortality.

Seeman MV.

Can J Psychiatry. 2007 Jan;52(1):55-60. Review.

PMID:
17444079
19.

Supplemental Content

Support Center